Table III.
Patient experiences during the luteal phase according to type of dosing and pretreatment AMH.
| Type of dosing and pretreatment AMH (pmol/L) | ||||||
|---|---|---|---|---|---|---|
| AMH 4–11.9 n = 43 |
AMH 12–23.9 n = 89 |
AMH 24–40 n = 40 |
||||
| AMH-based | Standard | AMH-based | Standard | AMH-based | Standard | |
| Abdominal distension, P = 0.13 | ||||||
| None | 2 (7.1) | 2 (13.3) | 5 (8.3) | 5 (17.2) | 0 (0.0) | 0 (0.0) |
| Mild | 17 (60.7) | 5 (33.3) | 29 (48.3) | 13 (44.8) | 11 (40.7) | 4 (30.8) |
| Moderate | 5 (17.9) | 8 (53.3) | 19 (31.7) | 10 (34.5) | 10 (37.0) | 6 (46.2) |
| Severe | 4 (14.3) | 0 (.0) | 7 (11.7) | 1 (3.4) | 6 (22.2) | 3 (23.1) |
| Abdominal pain, P = 0.90 | ||||||
| None | 4 (14.3) | 2 (13.3) | 7 (11.7) | 2 (6.9) | 3 (11.1) | 0 (0.0) |
| Mild | 11 (39.3) | 5 (33.3) | 28 (46.7) | 15 (51.7) | 16 (59.3) | 7 (53.8) |
| Moderate | 11 (39.3) | 5 (33.3) | 19 (31.7) | 8 (27.6) | 5 (18.5) | 5 (38.5) |
| Severe | 2 (7.1) | 3 (20.0) | 6 (10.0) | 4 (13.8) | 3 (11.1) | 1 (7.7) |
| Dyspnoea, P = 0.21 | ||||||
| None | 17 (60.7) | 13 (86.7) | 41 (68.3) | 20 (69.0) | 11 (40.7) | 9 (69.2) |
| Mild | 10 (35.7) | 2 (13.3) | 16 (26.7) | 7 (24.1) | 11 (40.7) | 2 (15.4) |
| Moderate | 1 (3.6) | 0 (0.0) | 2 (3.3) | 2 (6.9) | 5 (18.5) | 2 (15.4) |
| Severe | 0 (0.0) | 0 (0.0) | 1 (1.7) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Grading of bleeding after transfer, P = 0.79 | ||||||
| Menstruation | 15 (83.3) | 9 (81.8) | 30 (73.2) | 13 (68.0) | 12 (75.0) | 7 (77.8) |
| Spotting | 3 (16.7) | 2 (18.2) | 11 (26.8) | 6 (32.0) | 4 (25.0) | 2 (22.2) |
Values are count and column proportions (%). No statistical differences between groups using Chi2-test.
Questionnaires were returned by 172 of 221 patients (22% missing data).